ESE is grateful to Ascendis Pharma
for being a Gold Sponsor of ECE 2026
Please visit them at exhibit booth 15
Sessions at ECE 2026
Satellite symposium
Sunday 10 May 2026, 12:50-14:05 CEST, Forum Hall
From Guidelines to Action: Advancing Hypoparathyroidism Care in 2026
Chair: Lorenz Hofbauer, Germany
- The Future of Hypoparathyroidism Care: Beyond Biochemical Control
Lorenz Hofbauer, Germany - What’s New: Key Updates of the 2025 ESE Hypoparathyroidism Guidelines
Neil Gittoes, UK - Navigating the Challenges: Translating Guidelines into Daily Practice
Maria Yavropoulou, Greece and Thomas Cuny, France - Meet the Experts: What Does Good Hypoparathyroidism Care Look Like in 2026
Panel Discussion - Putting it All Together: Key Takeaways for Optimized Hypoparathyroidism Care
Lorenz Hofbauer, Germany
Mini-satellite
Monday 10 May 2026, 10:45-11:15 CEST, South Hall 1
From Symptoms to Stories: The Patient Perspective on Hypoparathyroidism
Chair: Karin Amrein, Austria
- In Conversation: Hypoparathyroidism Beyond Clinical Metrics
Karin Amrein, Austria and Fabienne Thiel, Germany
Abstracts at ECE 2026
Oral Presentation: Five-Year Data Report from the Phase 2 PaTH Forward Trial of Palopegteriparatide for Adults with Hypoparathyroidism
Presenting Author: Andrea Palermo, MD, PhD
ePoster: Global Prevalence Estimates of Adult Growth Hormone Deficiency (AGHD): A Targeted Literature Review and Meta-Analysis [2015-2025]
Presenting Author: Subhara Raveendran, PhD